Principal Financial Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-24,702
| Closed | -$532K | – | 2374 |
|
|
2024
Q2 | $532K | Sell |
24,702
-6,072
| -20% | -$131K | ﹤0.01% | 1938 |
|
|
2024
Q1 | $829K | Buy |
30,774
+12,811
| +71% | +$345K | ﹤0.01% | 1895 |
|
|
2023
Q4 | $538K | Buy |
17,963
+661
| +4% | +$19.8K | ﹤0.01% | 1950 |
|
|
2023
Q3 | $355K | Sell |
17,302
-28
| -0.2% | -$574 | ﹤0.01% | 2015 |
|
|
2023
Q2 | $344K | Buy |
17,330
+1,333
| +8% | +$26.5K | ﹤0.01% | 2040 |
|
|
2023
Q1 | $274K | Buy |
15,997
+2,268
| +17% | +$38.9K | ﹤0.01% | 2105 |
|
|
2022
Q4 | $269K | Buy |
13,729
+1,752
| +15% | +$34.3K | ﹤0.01% | 2130 |
|
|
2022
Q3 | $191K | Buy |
+11,977
| New | +$191K | ﹤0.01% | 2217 |
|
|
2021
Q4 | – | Sell |
-20,614
| Closed | -$616K | – | 2610 |
|
|
2021
Q3 | $616K | Buy |
20,614
+278
| +1% | +$8.31K | ﹤0.01% | 2118 |
|
|
2021
Q2 | $900K | Buy |
20,336
+97
| +0.5% | +$4.29K | ﹤0.01% | 2063 |
|
|
2021
Q1 | $898K | Buy |
20,239
+211
| +1% | +$9.36K | ﹤0.01% | 2020 |
|
|
2020
Q4 | $1.1M | Buy |
20,028
+9,209
| +85% | +$505K | ﹤0.01% | 1925 |
|
|
2020
Q3 | $247K | Buy |
10,819
+57
| +0.5% | +$1.3K | ﹤0.01% | 2159 |
|
|
2020
Q2 | $225K | Buy |
+10,762
| New | +$225K | ﹤0.01% | 2157 |
|